GeoVax Labs

Biotechnology Research • Smyrna, Georgia, United States • 21-50 Employees

Company overview

Headquarters	1900 Lake Park Drive, Suite 380, Smyrna, GA 30080, US
Phone number	+16783847220
Website	geovax.com
NAICS	541714
SIC	873
Keywords	Biotechnology, Immuno-Oncology, Cancer Vaccine Development, Ebola Vaccine, Hemorrhagic Fever Virus Vaccine, Hepatitis B Vaccine, Hiv/Aids Vaccine Development, Malaria Vaccine, Zika Virus Vaccine, Covid-19, Lassa Fever Vaccine
Employees	21-50
Socials

Key Contacts at GeoVax Labs

Ashley Zuniga

Director, Project Management | Biotech

Kathleen A. Walker

Senior Director, Vaccine Development

Arban Domi

Director, Vaccine Development

Marc Pipas

Executive Medical Director

Harriet L. Robinson

Director Hiv Vaccines

Arban Domi

Director Vector Development

Dean Kollintzas

Director

GeoVax Labs Email Formats

GeoVax Labs uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@geovax.com), used 88.5% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@geovax.com	88.5%
{first name}{last name}	johndoe@geovax.com	7.7%
{last name}{last name}	doedoe@geovax.com	3.8%

About GeoVax Labs

GeoVax Labs, Inc., (NASDAQ: GOVX) is a clinical-stage biotechnology company developing human vaccines against infectious diseases using our Modified Vaccinia Ankara - Virus-Like Particle (MVA-VLP) vaccine platform. Our current development programs are focused on vaccines against COVID-19; Hemorrhagic Fever viruses such as Ebola (Zaire, Sudan), Lassa and Marburg; Malaria and Zika virus; and, Human Immunodeficiency Virus (HIV). We have also initiated programs to develop a broadly applicable immunotherapy against tumor associated antigen MUC1 that is expressed of many solid tumor types including breast, ovarian, gastric, liver, pancreas, renal and lymph nodes and immunotherapy to treat human papilloma virus (HPV)-induced cancers. For more information, visit www.geovax.com.

GeoVax Labs revenue & valuation

Annual revenue	$6,143,044
Revenue per employee	$212,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$19,700,000
Total funding	$63,500,000